Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Barak Shapira, Ronny Berkovitz, Paola Rosca, Shaul Lev-Ran, Alexander Kaptsan & Yehuda Neumark. (2021) Why Switch? - Motivations for Self-Substitution of Illegal Drugs. Substance Use & Misuse 56:5, pages 627-638.
Read now
Read now
Ian P. Albery, Antony C. Moss, Nicola Davidson, S. Mba, Ursula Blaszko & Alexander P. Marchant. (2018) Selective attentional bias for novel psychoactive substance (NPS) and expectancy-related stimuli among nonproblematic NPS users and never NPS users. Journal of Substance Use 23:4, pages 422-428.
Read now
Read now
József Rácz, Róbert Csák & Sándor Lisznyai. (2015) Transition from “old” injected drugs to mephedrone in an urban micro segregate in Budapest, Hungary: a qualitative analysis. Journal of Substance Use 20:3, pages 178-186.
Read now
Read now
Marie Claire Van Hout. (2014) An Internet Study of User’s Experiences of the Synthetic Cathinone 4-Methylethcathinone (4-MEC). Journal of Psychoactive Drugs 46:4, pages 273-286.
Read now
Read now
Jodie Norman, Sharon Grace & Charlie Lloyd. (2014) Legal high groups on the internet – The creation of new organized deviant groups?. Drugs: Education, Prevention and Policy 21:1, pages 14-23.
Read now
Read now
Articles from other publishers (9)
Barak Shapira, Paola Rosca, Ronny Berkovitz, Igor Gorjaltsan & Yehuda Neumark. (2020) The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users. PeerJ 8, pages e9461.
Crossref
Crossref
Máté Kapitány-Fövény, Anna Kiss, Judit Farkas, Kinga Edit Kuczora, Patrícia Pataki, Janka Horváth & Zsolt Demetrovics. (2020) Childhood Trauma, Cognitive Emotion Regulation and Motivation for Behavior Change Among Clients of Opioid Substitution Treatment With and Without Past Year Synthetic Cathinone Use During Therapy. Frontiers in Neuroscience 14.
Crossref
Crossref
Lewis Jones, Phil Reed & Andrew Parrott. (2016) Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users. Journal of Psychopharmacology 30:12, pages 1313-1320.
Crossref
Crossref
Sinead E Shortall, A Richard Green, Kevin CF Fone & Madeleine V King. (2016) Caffeine alters the behavioural and body temperature responses to mephedrone without causing long-term neurotoxicity in rats. Journal of Psychopharmacology 30:7, pages 698-706.
Crossref
Crossref
Chris Wilkins, Paul Sweetsur & Karl Parker. (2014) The impact of the prohibition of benzylpiperazine (BZP) “legal highs” on the availability, price and strength of BZP in New Zealand. Drug and Alcohol Dependence 144, pages 47-52.
Crossref
Crossref
Nina O'Neill. (2014) Mephedrone and Multiplicity: User Accounts of Effects and Harms. Contemporary Drug Problems 41:3, pages 417-443.
Crossref
Crossref
Débora González, Mireia Ventura, Fernando Caudevilla, Marta Torrens & Magi Farre. (2013) Consumption of new psychoactive substances in a Spanish sample of research chemical users. Human Psychopharmacology: Clinical and Experimental 28:4, pages 332-340.
Crossref
Crossref
Karenza Moore, Paul I. Dargan, David M. Wood & Fiona Measham. (2013) Do Novel Psychoactive Substances Displace Established Club Drugs, Supplement Them or Act as Drugs of Initiation The relationship between Mephedrone, Ecstasy and Cocaine. European Addiction Research 19:5, pages 276-282.
Crossref
Crossref
Rebekah Brennan & Marie Claire Van Hout. (2012) Miaow miaow: a review of the new psychoactive drug mephedrone. Drugs and Alcohol Today 12:4, pages 241-253.
Crossref
Crossref